Kendra Sweet

11PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsHaematologyHaematological tumoursCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 12, 2026
Nilotinib in chronic myeloid leukemia: clinical value, real-world challenges, and the potential of nilotinib tablets to improve therapeutic outcomes.

|Feb 11, 2026
Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents.

Dimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni

|Dec 02, 2024
Clinical perspectives on post-induction maintenance therapy in patients with acute myeloid leukaemia in remission who are ineligible for allogeneic haematopoietic stem cell transplantation.

Kendra Sweet, Thomas Cluzeau

|Sep 14, 2023
Drivers of deep molecular response and long-term outcomes in patients with core binding factor acute myeloid leukemia.

Parth C Patel, Somedeb Ball, Akriti G Jain

|Dec 22, 2022
Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia.

Kendra L Sweet, Jorge E Cortes, Jane F Apperley

|Jul 18, 2020
Favorable outcomes of acute leukemias of ambiguous lineage treated with hyperCVAD: a multi-center retrospective study.

Vu H Duong, Kebede H Begna, Sarah Kashanian

Pageof 2

Frequent Collaborators

6 joint publications

Jeffrey Lancet

6 joint publications

Rami S Komrokji

5 joint publications

Andrew T Kuykendall

5 joint publications

David Sallman